John Hussman's NUVB Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 210,000 shares of Nuvation Bio Inc. (NUVB) worth $1.18 M, representing 0.25% of the portfolio. First purchased in 2026-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, John Hussman has maintained this position in NUVB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 210,000 shares. Largest reduction occurred in Q2 2026, reducing 105,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Nuvation Bio (NUVB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvation Bio (NUVB) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +210,000 | New Buy | 210,000 | $5.60 |
| Q2 2026 | -105,000 | Sold Out | 0 | $0.00 |
| Q1 2026 | +105,000 | New Buy | 105,000 | $4.29 |
John Hussman's Nuvation Bio Investment FAQs
John Hussman first purchased Nuvation Bio Inc. (NUVB) in Q1 2026, acquiring 105,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Nuvation Bio Inc. (NUVB) for 3 quarters since Q1 2026.
John Hussman's largest addition to Nuvation Bio Inc. (NUVB) was in Q3 2026, adding 210,000 shares worth $1.18 M.
According to the latest 13F filing for Q3 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 210,000 shares of Nuvation Bio Inc. (NUVB), valued at approximately $1.18 M.
As of the Q3 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.25% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Nuvation Bio Inc. (NUVB) was 210,000 shares, as reported at the end of Q3 2026.